Orgenesis specializes in development of engineered solutions for complex biological processes in CGT processing by developing OMPUL™ to be a fully integrated, closed loop all-in-one bioprocessing unit.
The POCare™ Platform overcomes conventional processing challenges by enabling high quality standards, sterile, scalable onsite processing of CGTs orchestrated by the POCare™ centers, servicing local hospitals and other customers. Manufacturing infrastructure is easily harmonized and reproducible using the OMPUL™, Orgenesis Mobile Processing Unit and Lab™ technology. It shortens implementation time from 18-24 to 3-6 months, offers a more cost-effective environment and enables local scalability by connecting additional OMPUL™.
Design is driven by the specific target level to be reached in the processing area. Grade A/B for open procedures or A/D for closed system and bio-isolator
Developing (with partners) fully closed isolation, transduction, expansion and harvest processes.
Customizable systems for simplified maintenance and flexibility
Developing (with partners) automated single-use sensors to improve monitoring and quality control with minimal operator involvement.
Enables simplified process scale-up / scale-out, condensing timeline for capacity expansion from ~24 months to ~4-6 months.
Supports secure digital batch monitoring and cloud-based data collection for traceability and quality assurance (QA).